Study to compare Centchroman vs. Tamoxifen for the management of breast pai
Phase 3
Completed
- Conditions
- Health Condition 1: null- mastalgia
- Registration Number
- CTRI/2012/05/002658
- Lead Sponsor
- niversity College of Medical Sciences University of Delhi Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 58
Inclusion Criteria
1. All patients having mastalgia with VAS score above 3/10
2. Duration of mastalgia > 3 months
Exclusion Criteria
1.Past history of breast carcinoma or family history of breast carcinoma.
2.Acute inflammatory breast conditions
3.Discrete breast lumps
4.Patients with oligomenorrhoea, irregular bleeding, ovarian cysts or cervical hyperplasia.
5.Lactation period â?? first 6 months
6.Pregnant or planning to conceive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain relief to VAS score 3/10 or lessTimepoint: 4 weeks <br/ ><br>8 weeks <br/ ><br>12 weeks <br/ ><br>24 weeks
- Secondary Outcome Measures
Name Time Method 1.Improvement in quality of life <br/ ><br>2.Side effects <br/ ><br>Timepoint: 24 weeks